505
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study

, , , , , , , & show all
Pages 63-69 | Received 17 Apr 2015, Accepted 08 Aug 2015, Published online: 04 Sep 2015
 

Abstract

Background: Numerous investigations on procalcitonin (PCT) have been carried out, although few with large sample size. To deal with the complexity of sepsis, an understanding of PCT in heterogeneous clinical conditions is required. Methods: Hospitalized patients aged 10–79 years were included in this retrospective and cross-sectional study. PCT tests were assayed within 2 days of blood culture. Results: A total of 2952 cases (from 2538 patients) were enrolled in this study, including 440 cases in the ‘positive BC’ group, 123 cases in the ‘positive body fluid culture’ group, and 2389 cases in the ‘negative all culture’ group. Median PCT values were 4.53 ng/ml, 2.95 ng/ml, and 0.49 ng/ml, respectively. Median PCT values in the gram-negative BC group and gram-positive BC group, respectively, were 6.99 ng/ml and 2.96 ng/ml. Median PCT values in the ‘positive hydrothorax culture’ group, ‘positive ascites culture’ group, ‘positive bile culture’ group, and ‘positive cerebrospinal fluid culture’ group, respectively, were 1.39 ng/ml, 8.32 ng/ml, 5.98 ng/ml, and 0.46 ng/ml. In all, 357 cases were classified into the ‘sepsis’ group, 150 of them were classified into the ‘severe sepsis’ group. Median PCT values were 5.63 ng/ml and 11.06 ng/ml, respectively. Conclusions: PCT could be used in clinical algorithms to diagnose positive infections and sepsis. Different PCT levels could be related to different kinds of microbemia, different infection sites, and differing severity of sepsis.

Acknowledgment

We especially appreciate the Laboratory Department in Zhujiang Hospital for providing the retrospective data in this study.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.